Z-2210-2023 Class II Ongoing

Recalled by Cytocell Ltd. — Cambridge, N/A

FDA device recall Z-2210-2023 was initiated by Cytocell Ltd. on May 24, 2023 and is designated Class II. Reason for recall: DNAs used during the manufacture of two affected models were accidentally inverted during manufacturing. The recall status is ongoing. Affected quantity: 61 units.

Recall details

Product Type
Devices
Report Date
Jul 26, 2023
Initiation Date
May 24, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
61 units

Product description

RET Distal Probe. Used in Fluorescence in situ hybridization (FISH), a laboratory technique for detecting and locating a specific DNA sequence on a chromosome.

Reason for recall

DNAs used during the manufacture of two affected models were accidentally inverted during manufacturing.

Distribution pattern

US Nationwide distribution in the states of CA, FL, OH, & SC.

Code information

Catalog No. LPS509-A; UDI-DI: 05055844900516; Lot No. 076764, 080124, 082129, 082560, 083247, 083550, 083850.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2210-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2210-2023. Report a data issue: hello@regdatalab.com.